potential indications for glp-1 receptor agonists keep expanding A glimpse of the future: new molecules and GLP1 π‘π GLP-1 Receptor Agonists, Fertility Restoration,
Description
doi: 10.1210/jc.2005-1093 122 DaviesMJBergenstalRBodeBKushnerRFLewinASkjthTVet al

The oral segment is expected to grow at the fastest CAGR in the coming years because of the increasing demand for convenient, needle-free treatment options that improve patient adherence and comfort

Discontinuing the medication is known to lead to rapid weight regain, creating a significant burden of having to take weekly injections throughout the treatment period

Patients who were prescribed these alternatives and suffered severe injuries such as intestinal obstruction, gastrointestinal disorders, or vision loss may also be eligible to file legal claims

Mediational analysis indicated that weight loss partially mediated the causal effects of GLP-1 RAs on depression and emotional lability, accounting for 18.28% (95% CI: 9.4627.10%, P = 0.038) and 7.65% (95% CI: 5.669.64%, P 0.01 to proxy for GLP-1 RAs exposure
